Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Therapie|September 1, 1996
[Acute drug-induced agranulocytosis: experience of the Regional Center of Pharmacovigilance of Lyon over 7 years]T Vial, C Pofilet, E Pham, et al.
Plant Disease|February 8, 2019
First Report of Powdery Mildew Caused by Podosphaera pannosa on Prunus cerasus in FranceJ Hubert, C Fourrier, C Payen, et al.
Acta Clinica Belgica|March 4, 2014
Epidemiology of MDR-TB in a Belgian infectious diseases unit: a 15 years reviewR van Heurck, M C Payen, S De Wit, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 4, 2007
Antipyretic efficacy and safety of a single intravenous administration of 15 mg/kg paracetamol versus 30 mg/kg propacetamol in children with acute fever due to infectionJ F Duhamel, E Le Gall, M L Dalphin, et al.
Annales D'Endocrinologie|July 1, 2008
User trial of Easypod, an electronic autoinjector for growth hormoneM Tauber, C Payen, A Cartault, et al.
Bulletin Du Cancer|August 1, 1993
[Deep venous thrombosis on implantable infusion devices. A prospective study of 72 patients with Doppler ultrasonography of veins of the neck (jugular, subclavian and brachiocephalic trunk)]A Pucheu, B Leduc, I Sillet-Bach, et al.
Acta Clinica Belgica|October 26, 2013
Meningitis and splenic infarction due to disseminated Mycobacterium genavense infection in an HIV patient. Case report and review of the literatureA Kyrilli, M C Payen, T Antoine-Moussiaux, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 20, 2011
[Acute paracetamol overdose during pregnancy: a case report]C Payen, S Cossa, D Riethmuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's diseaseJ M Andrieu, N Ifrah, C Payen, et al.
Annales De Cardiologie Et D'Angeiologie|February 1, 1996
[Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices]A Pucheu, B Leduc, I Sillet-Bach, et al.
Pageof 5